Seqens Seqens

X

Digital content for Nimbus Therapeutics

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Nimbus Therapeutics
United_States_of_America Flag

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.businesswire.com/news/home/20240312957107/en

BUSINESSWIRE
12 Mar 2024

https://www.businesswire.com/news/home/20240105723104/en

BUSINESSWIRE
05 Jan 2024

https://www.businesswire.com/news/home/20231218379770/en

BUSINESSWIRE
18 Dec 2023

https://www.businesswire.com/news/home/20231031439253/en

BUSINESSWIRE
31 Oct 2023

https://www.businesswire.com/news/home/20230906187005/en

BUSINESSWIRE
06 Sep 2023

https://www.fiercebiotech.com/biotech/takedas-4b-drug-clears-psoriasis-one-third-patients-laying-down-marker-bid-challenge-bms

Nick Paul Taylor FIERCE BIOTECH
20 Mar 2023

https://www.businesswire.com/news/home/20230214005309/en

BUSINESSWIRE
14 Feb 2023

https://www.biospace.com/article/releases/takeda-completes-acquisition-of-nimbus-therapeutics-tyk2-program-subsidiary/?s=79

BIOSPACE
09 Feb 2023

https://www.biopharmadive.com/news/nimbus-takeda-deal-jeb-keiper-llc-troubled-water/638931/

BIOPHARMADIVE
16 Dec 2022

https://www.reuters.com/markets/deals/takeda-buy-inflammatory-disease-drug-4-bln-nimbus-2022-12-13/

REUTERS
14 Dec 2022
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY